Reverse Innovation in Health Care: How to Make Value-Based Delivery Work

Description

Two experts in reverse innovation reveal four different pathways for providing value-based health care and show how these, and other revolutionary practices from India, are being adopted in areas across the United States. Reveals how some far-sighted US providers are practicing health care delivery innovations similar to those in originating in India, illustrating how reverse innovation is helping to transform US health care. Presents 7 Indian "exemplars" and shows how they have created a breakthrough business model to consistently deliver high-quality health care at low cost. Explains how these Indian providers are practicing the kind of value-based competition advocated by Michael Porter and Elizabeth Teisberg in their book Redefining Health Care, and how these practices are being adopted in the US context, without regulatory mandates or system-wide reforms. Audience: Executives of health care organizations around the world, health insurance companies, and Fortune 500 companies that develop drugs, medical devices, and new procedures, and biotech firms Startups in Silicon Valley and elsewhere looking to disrupt existing practices in the health care sector Health care policymakers Academics and consultants working in health care Announced first printing: 15,000 Laydown goal: 4,000

Vijay Govindarajan is one of the world's leading experts on strategy and innovation and is the Coxe Distinguished Professor at Dartmouth's Tuck School of Business and a former Marvin Bower Fellow at Harvard Business School. He is the author of a number of influential books, including the New York Times and Wall Street Journal bestselling Reverse Innovation. Ravi Ramamurti, a top scholar in international business, is the University Distinguished Professor of International Business & Strategy and Director of the Center for Emerging Markets at Northeastern University in Boston. His research and consulting work focuses on strategy and innovation by firms operating in, or from, emerging economies. He is the author or editor of seven books, including Understanding Multinationals from Emerging Markets.

Advance Praise for Reverse Innovation in Health Care: Kenneth L. Davis, MD, President and CEO, Mount Sinai Health System, New York City-- "A provocative volume of ideas." Robert Pearl, MD, professor, Stanford University School of Medicine; author, Mistreated: Why We Think We're Getting Good Health Care--and Why We're Usually Wrong-- ". . . a must-read for both health-care leaders and policy experts." Donald M. Berwick, MD, President Emeritus, Institute for Healthcare Improvement; former Administrator, Centers for Medicare & Medicaid Services-- "If American health-care leaders . . . do not take this astounding book seriously, shame on them." Mary Ackenhusen, President and CEO, Vancouver Coastal Health, Canada-- "Reverse Innovation in Health Care offers inspirational and practical insights. It will be required reading for my leadership team." Judd A. Gregg, former US Senator-- ". . . should be part of any consideration of how we improve America's health-care system." Tawfig Al Rabiah, Minister of Health, Saudi Arabia-- "Reverse Innovation in Health Care is a great and well-rounded approach to tackling many of the current health-care issues." John Cochran, MD, former Executive Director, Kaiser Permanente Federation-- "This book is timely and very important for American physicians, health-care executives, and legislators to read. Many of these case studies are very portable." Toby Cosgrove, MD, former President and CEO, Cleveland Clinic-- ". . . a rich new source of cost-saving medical innovation that deserves our most serious attention."